Dr. Ira Hughes Thorla Jr., MD

Dr. Thorla practices at Louisiana Dermatology Associates in Baton Rouge, Louisiana.

Dr. Thorla's NPI, 1730178047, was assigned on October 19, 2005. Dr. Thorla graduated from Louisiana State University School of Medicine in New Orleans in 1995. Dr. Thorla holds Louisiana license 022785.

Dr. Thorla's primary practice is Louisiana Dermatology Associates, at 10154 Jefferson Hwy, Baton Rouge, LA 70809 in East Baton Rouge Parish. The practice phone is (225) 490-0812.

Dr. Thorla's primary practice is Louisiana Dermatology Associates in Baton Rouge, Louisiana. The medical group on file is Louisiana Dermatology Associates. Dmand AI also links Dr. Thorla to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thorla practices. Vendor and product names are available with a free account.

Dermatology is Dr. Thorla's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Thorla is licensed in Louisiana.

CMS data shows 2,975 Medicare services from Dr. Thorla across 22 procedure codes in 2024, for 613 Medicare patients. Medicare paid $92,536 for them. Every service was in an office.

CMS counts 613 Medicare patients who saw Dr. Thorla in 2024. The largest group is 65 to 74, with 292 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Thorla's median patient age at 70, with 53% women.

In 2024, Dr. Thorla wrote 4,181 Medicare Part D claims for 1,020 patients. 96% of them were for generic drugs. CMS names the drug for 4,008 of them, across 42 drugs with 11 or more claims each, at $599,638 in total drug cost. In 2023, CMS named 3,624 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Thorla for performance year 2024, reported as part of a group. Dr. Thorla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 901 procedures of removal of skin lesions by Dr. Thorla, more than 92% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Thorla in 2022. Dr. Thorla's most frequent co-author is John Caleb Browning, MD.

Dmand AI links Dr. Thorla to 5 clinical trials, 2 of them phase 3 studies. Conditions studied include Psoriasis, Skin Diseases, Papulosquamous and Pruritus. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Thorla that name 6 trials.

CMS Open Payments shows 1,670 general payments to Dr. Thorla from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Pfizer Inc. paid the most, $14,381. It also lists 21 research payments totaling $45,896 from 2016 to 2024, naming 6 clinical trials.

Dr. Thorla graduated from Louisiana State University School of Medicine in New Orleans in 1995.